Expanding the Orphanage for Orphan Drugs

Here's a great article outlining the IDSA's efforts to work with the FDA to expand the definition of “orphan” drug to include antibiotics. I think we can all agree that these agents have been treated like unwanted foster stepchildren by pharma. Perhaps this can be the “game changer”?! http://www.fiercebiotech.com/story/fda-nudged-treat-antibiotics-rare-disease-drugs/2012-03-09

Read More Expanding the Orphanage for Orphan Drugs

MRSA, Superbugs and SALSA: Where do we go from here?

With the ever increasing rise in prevalence of “superbugs” and methicillin-resistant Staphylococcal species in hospitals, clinics and public/private places around the world, it seems that both clinicians and their patients have taken a significant interest in this area. Recently, we developed a series of lectures on this topic it is available here.  Enjoy. 

Read More MRSA, Superbugs and SALSA: Where do we go from here?